FDA Approved: YASMIN — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for YASMIN (drospirenone and ethinyl estradiol) submitted by Bayer HealthCare Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Yasmin (drospirenone/ethinyl estradiol)

Snippet

SUPPL AP for YASMIN (DROSPIRENONE AND ETHINYL ESTRADIOL)